Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: September 2023

MissionIRNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Announces Record Capacity Levels for Fr8Fleet

Posted on September 6, 2023 by MissionIR

Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”) is a technology company offering its custom-developed Fr8App, an industry-leading freight-matching platform that offers a B2B cloud-based solution for cross-border and domestic shipping within the USMCA region. The company reported a record number of active … Continue reading →

Posted in Freight Technologies Inc. FRGT | Leave a comment

MissionIRNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP), RippleLink Partner to Provide Private LTE, Enhanced Connectivity to ASR Customers

Posted on September 6, 2023 by MissionIR

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, is collaborating with RippleLink, a Private LTE systems integrator. The partnership will provide Private LTE design and deployment services designed to offer “blazing … Continue reading →

Posted in Knightscope Inc. KSCP | Leave a comment

MissionIRNewsBreaks – Longeveron Inc. (NASDAQ: LGVN) to Present at Upcoming H.C. Wainwright Global Investment Conference

Posted on September 5, 2023 by MissionIR

Longeveron (NASDAQ: LGVN, LGVNR), a clinical stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left heart syndrome (“HLHS”), Alzheimer’s disease and Aging-related Frailty, today announced that its management will be participating in the … Continue reading →

Posted in Longeveron Inc. LGVN | Leave a comment

MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Participation at Upcoming H.C. Wainwright Global Investment Conference

Posted on September 5, 2023 by MissionIR

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, will be presenting at the 25th annual H.C. Wainwright Global Investment Conference. The conference … Continue reading →

Posted in CNS Pharmaceuticals Inc. CNSP | Leave a comment

MissionIRNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) CEO to Present at Upcoming H.C. Wainwright Conference

Posted on September 5, 2023 by MissionIR

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots and blue light emergency communication systems, has announced that it will present virtually at the H.C. Wainwright 25th Annual Global Investment Conference taking place on Monday, Sept. 11, 2023. The … Continue reading →

Posted in Knightscope Inc. KSCP | Leave a comment

Genprex Inc. (NASDAQ: GNPX) Obtains New License for Novel Diabetes Gene Therapy Pipeline

Posted on September 5, 2023 by MissionIR

Clinical-stage cancer and diabetes gene therapy developer Genprex (NASDAQ: GNPX) continues to expand its intellectual property portfolio for the company’s diabetes gene therapy program, recently announcing that it has entered into an exclusive license agreement related to a particular gene … Continue reading →

Posted in Genprex Inc. GNPX | Leave a comment

As REE Miners Face Impediments to Refining Independence, Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Develops Supply Chain Technology Based in North America

Posted on September 5, 2023 by MissionIR

A recent Reuters report on the challenges facing rare earth (“REE”) processing companies outside of China underscores the potential market opportunity awaiting critical technology metals supply chain innovator Ucore Rare Metals (TSX.V: UCU) (OTCQX: UURAF), as Ucore works to bring … Continue reading →

Posted in Ucore Rare Metals Inc. UURAF | Leave a comment

MissionIRNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Positioned Favorably with Worldwide License to Anti-IL-17 NanoAbs

Posted on September 1, 2023 by MissionIR

BiondVax (NASDAQ: BVXV), a biotechnology company that recently signed an exclusive worldwide license to develop and commercialize innovative alpaca-derived nanosized antibodies (“NanoAbs”) targeting IL-17 cytokines as treatments for psoriasis and psoriatic arthritis, recently received coverage in analysis by Aegis Capital … Continue reading →

Posted in BiondVax Pharmaceuticals Ltd. BVXV | Leave a comment

MissionIRNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Secures Patent Protection in ‘Some of the Most Important Markets in the World’

Posted on September 1, 2023 by MissionIR

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, recently received a patent from the China National Intellectual Property Administration. “The granted patent broadly covers the use of the company’s … Continue reading →

Posted in Genprex Inc. GNPX | Leave a comment

MissionIRNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) K5 and K1 ASRs to Patrol New York-Based Pharmaceutical Facility

Posted on September 1, 2023 by MissionIR

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, has announced a new 7-robot contract with a publicly traded biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious … Continue reading →

Posted in Knightscope Inc. KSCP | Leave a comment